A new model in mental health, rooted in Switzerland

The Foundation was established as an independent, non-profit entity, now officially
recognised as serving the public good – with the mission of making this form of care
accessible to all.

Bringing together training, applied research, and therapeutic support under one roof is a pioneering initiative. It stems from a deep conviction: that those who have personally experienced transformation hold valuable knowledge to share with healthcare professionals, researchers, anthropologists and therapists—together shaping new models of care.

12,5 %

of the global population (970 million people) were affected by a mental disorder in 2019 (World Health Organization).

9 %

of people in Switzerland suffered from depression in 2017—almost twice the global average of 5% (Federal Statistical Office).

1/3

patients with major depression do not respond effectively to conventional treatments and fall into the category of Treatment-Resistant Depression (Journal of Clinical Psychiatry).

6 to 12 months

estimated waiting time for Psychedelic-Assisted Therapy (PAT) in Switzerland.

Switzerland is one of the few countries in the world where Psychedelic-Assisted Therapy is authorised, within a legal and secure framework (FOPH).

We strive to advance research, support patients and assist healthcare professionals, so that these innovative therapies can bring about lasting change in mental healthcare.

Definition: Psychedelic-Assisted Therapy (PAT) is an innovative therapeutic approach that combines the supervised use of psychedelic substances such as psilocybin, MDMA, or LSD with psychotherapeutic support. In this context, these substances are not used in isolation but act as catalysts for deep psychological work, helping individuals access transformative inner experiences.